<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Isfahan University of Medical Sciences</PublisherName>
				<JournalTitle>Health Information Management</JournalTitle>
				<Issn>1735-7853</Issn>
				<Volume>13</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>06</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Comparison of Increase in Medication Costs and Medication Funding Per Capita of ‎the ‎Outpatients Insured by the Iranian Salamat Insurance in Isfahan, Iran‎</ArticleTitle>
<VernacularTitle>Comparison of Increase in Medication Costs and Medication Funding Per Capita of ‎the ‎Outpatients Insured by the Iranian Salamat Insurance in Isfahan, Iran‎</VernacularTitle>
			<FirstPage>132</FirstPage>
			<LastPage>137</LastPage>
			<ELocationID EIdType="pii">11505</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Hosseinali</FirstName>
					<LastName>Ghasemi</LastName>
<Affiliation>MSc, Drug Supervision, Islamic Azad University, Shahreza Branch, Isfahan, Iran‎</Affiliation>

</Author>
<Author>
					<FirstName>Mahdieh</FirstName>
					<LastName>Raeeszadeh</LastName>
<Affiliation>Assistant Professor, Pharmacology, Department of Basic Sciences, School of Veterinary ‎Medicine, Islamic Azad University, Sanandaj ‎Branch, Sanandaj, Iran ‎</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2015</Year>
					<Month>05</Month>
					<Day>27</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: Medication and its cost in the country&#039;s health care system are of grave importance. Thus, the ‎aim of this study was to investigate the increase in medication costs in comparison to the ‎increase in medication funding per capita of the outpatients insured by the Iranian Salamat ‎Insurance in Isfahan, Iran. Methods: This was a descriptive-analytic study. The data were collected using an information form ‎including the variables of pharmaceutical expenditure, pharmaceutical expenditure per capita, ‎the number of insured per city, approved cost per capita, operating cost per capita, the number ‎of pharmacies, expensive drugs, drugs with the highest rate per capita, and drugs with the ‎highest frequency of use. The collected data were analyzed using descriptive statistics and the ‎Pearson correlation coefficient. Results: From 2009 to 2013, the drug costs constituted, respectively, 25, 23, 22, 22, and 31 percent ‎of the total health care costs of the Iranian Salamat Insurance. Amount per capita in 2013 ‎compared to years 2009, 2010, 2011, and 2012 were 58, 49, 28, and 21 percent higher, ‎respectively. Drug operating cost and its growth rate had increased during the studied 5 ‎years, compared to the approved costs per capita. More than half of the total drug cost in ‎‎2009-2013 was allocated to the 35 most expensive drugs. The Pearson correlation showed ‎that with increase in operating cost, the number of visits to pharmacies decreased. Conclusion: Revision of drug reimbursement, substitution of lower-cost drugs, and modification of the ‎prescription pattern used by physicians can be effective in the optimization of drug costs.</Abstract>
			<OtherAbstract Language="FA">Introduction: Medication and its cost in the country&#039;s health care system are of grave importance. Thus, the ‎aim of this study was to investigate the increase in medication costs in comparison to the ‎increase in medication funding per capita of the outpatients insured by the Iranian Salamat ‎Insurance in Isfahan, Iran. Methods: This was a descriptive-analytic study. The data were collected using an information form ‎including the variables of pharmaceutical expenditure, pharmaceutical expenditure per capita, ‎the number of insured per city, approved cost per capita, operating cost per capita, the number ‎of pharmacies, expensive drugs, drugs with the highest rate per capita, and drugs with the ‎highest frequency of use. The collected data were analyzed using descriptive statistics and the ‎Pearson correlation coefficient. Results: From 2009 to 2013, the drug costs constituted, respectively, 25, 23, 22, 22, and 31 percent ‎of the total health care costs of the Iranian Salamat Insurance. Amount per capita in 2013 ‎compared to years 2009, 2010, 2011, and 2012 were 58, 49, 28, and 21 percent higher, ‎respectively. Drug operating cost and its growth rate had increased during the studied 5 ‎years, compared to the approved costs per capita. More than half of the total drug cost in ‎‎2009-2013 was allocated to the 35 most expensive drugs. The Pearson correlation showed ‎that with increase in operating cost, the number of visits to pharmacies decreased. Conclusion: Revision of drug reimbursement, substitution of lower-cost drugs, and modification of the ‎prescription pattern used by physicians can be effective in the optimization of drug costs.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Drug Costs</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cost Analysis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Insurance</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://him.mui.ac.ir/article_11505_d8d855c465198499868fb2b566ebee8d.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
